BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 23850064)

  • 41. Etiology of Papilledema in Patients in the Eye Clinic Setting.
    Crum OM; Kilgore KP; Sharma R; Lee MS; Spiegel MR; McClelland CM; Bhatti MT; Chen JJ
    JAMA Netw Open; 2020 Jun; 3(6):e206625. PubMed ID: 32484553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience.
    Shah VA; Kardon RH; Lee AG; Corbett JJ; Wall M
    Neurology; 2008 Feb; 70(8):634-40. PubMed ID: 18285538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoscopic Optic Nerve Sheath Fenestration for Treatment of Papilledema Secondary to Intracranial Venous Hypertension: Report of Two Cases.
    Tirakotai W; Masaya-Anon P; Suwansanya J; Sitthimongkon U; Roongpuvapaht B
    J Med Assoc Thai; 2016 Jun; 99 Suppl 3():S141-6. PubMed ID: 29901363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
    ; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optic nerve decompression surgery improves visual function in patients with pseudotumor cerebri.
    Kelman SE; Heaps R; Wolf A; Elman MJ
    Neurosurgery; 1992 Mar; 30(3):391-5. PubMed ID: 1620303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Idiopathic Intracranial Hypertension Without Papilledema With Improvement in Visual Field Defect Following Optic Nerve Sheath Fenestration.
    Scofield-Kaplan SM; Patel K; Jones FR; Hogan RN
    J Neuroophthalmol; 2021 Mar; 41(1):e31-e33. PubMed ID: 31856069
    [No Abstract]   [Full Text] [Related]  

  • 47. Unilateral papilledema in 'benign' intracranial hypertension (pseudotumor cerebri).
    Sher NA; Wirtschafter J; Shapiro SK; See C; Shapiro I
    JAMA; 1983 Nov; 250(17):2346-7. PubMed ID: 6632132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Misconceptions in diagnosis and treatment of papilledema caused by idiopathic intracranial hypertension].
    Jiang LB; Zhang J
    Zhonghua Yan Ke Za Zhi; 2023 May; 59(5):342-346. PubMed ID: 37151004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Visual outcomes following optic nerve sheath fenestration via the medial transconjunctival approach.
    Vaidya NS; Mahmoud AM; Buzzacco D; Katz SE
    Orbit; 2016 Oct; 35(5):271-7. PubMed ID: 27541942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visual recovery after unilateral optic nerve sheath fenestration for pseudotumor cerebri syndrome.
    Dai YL; Ramsey DJ; Athappilly GK; Tucker SM
    Orbit; 2023 Aug; 42(4):397-403. PubMed ID: 36069075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinico-radiological correlation of magnetic resonance imaging findings in patients with idiopathic intracranial hypertension.
    Wong H; Sanghera K; Neufeld A; Maxner C; Shankar JJS
    Neuroradiology; 2020 Jan; 62(1):49-53. PubMed ID: 31506733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of Magnetic Resonance Imaging Features for Improving the Diagnosis of Idiopathic Intracranial Hypertension Without Papilledema.
    Mallery RM; Rehmani OF; Woo JH; Chen YJ; Reddi S; Salzman KL; Pinho MC; Ledbetter L; Tamhankar MA; Shindler KS; Digre KB; Friedman DI; Liu GT
    J Neuroophthalmol; 2019 Sep; 39(3):299-307. PubMed ID: 30829949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurofilament light chain marks severity of papilledema in idiopathic intracranial hypertension.
    Knoche T; Gaus V; Haffner P; Kowski A
    Neurol Sci; 2023 Jun; 44(6):2131-2135. PubMed ID: 36689008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical course of asymptomatic patients with papilledema from idiopathic intracranial hypertension.
    Rohani N; Foroozan R
    Can J Ophthalmol; 2023 Aug; 58(4):324-327. PubMed ID: 35304137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Idiopathic intracranial hypertension presenting with isolated unilateral facial nerve palsy: a case report.
    Samara A; Ghazaleh D; Berry B; Ghannam M
    J Med Case Rep; 2019 Apr; 13(1):94. PubMed ID: 30999940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Intra-orbital decompression of the optic nerve by opening the peri-optic meninges in the treatment of severe optic neuropathies complicating benign intracranial hypertension].
    Villain M; Candon E; Adenis JP; Arnaud B; Frerebeau P
    Neurochirurgie; 1999 May; 45(2):118-23. PubMed ID: 10448651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unilateral Papilledema in Idiopathic Intracranial Hypertension: A Case Series.
    Swinkin E; Jabehdar Maralani P; Sundaram AN
    Can J Neurol Sci; 2022 Mar; 49(2):278-281. PubMed ID: 33888167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of Optic Nerve Appearance on Visual Outcome in Pediatric Idiopathic Intracranial Hypertension.
    Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Newman NJ; Biousse V; Peragallo JH
    Can J Neurol Sci; 2020 Sep; 47(5):661-665. PubMed ID: 32362301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Update on Idiopathic Intracranial Hypertension.
    Wall M
    Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Idiopathic intracranial hypertension: relation between obesity and visual outcomes.
    Szewka AJ; Bruce BB; Newman NJ; Biousse V
    J Neuroophthalmol; 2013 Mar; 33(1):4-8. PubMed ID: 22217456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.